Le Lézard
Classified in: Business

Exercise of Warrants of Willow Biosciences Inc. By Tuatara Capital Fund II, L.P.


/NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW./

CALGARY, AB, March 4, 2021 /CNW/ - Pursuant to the early warning requirements of applicable Canadian securities laws, Tuatara Capital Fund II, L.P. ("Tuatara") reports that, on March 1, 2021, it acquired 1,000,000 common shares ("Common Shares") in the capital of Willow Biosciences Inc. ("Willow") through its exercise of warrants in the capital of Willow ("Warrants").

The Warrants were previously acquired on October 29, 2020, and were exercised at a price of $0.85 per Warrant (the "Warrant Exercise").

Immediately prior to the Warrant Exercise, Tuatara held: (a) 25,048,476 Common Shares; and (b) Warrants exercisable for a total of 5,609,695 Common Shares, representing 25.9% (on a non-diluted basis) and 24.1% (on a fully diluted basis) of the voting securities of Willow.

Following the Warrant Exercise, Tuatara holds: (a) 26,048,476 Common Shares; and (b) Warrants exercisable for a total of 4,609,695 Common Shares, representing 21.1% (on a non-diluted basis) and 21.0% (on a fully diluted basis) of the voting securities of Willow.

Tuatara acquired the Common Shares for investment purposes and may, in the future, increase or decrease its ownership of securities of Willow, directly or indirectly, from time to time depending upon, among other things, the business and prospects of Willow and future market conditions.

For further details regarding the exercise of Warrants described above, see the Early Warning Report dated March 4, 2021 available on Willow's SEDAR profile.

FOR FURTHER INFORMATION OR TO OBTAIN A COPY OF THE EARLY WARNING REPORT FILED IN CONJUNCTION WITH THIS NEWS RELEASE, PLEASE CONTACT:

Tuatara Capital Fund II, L.P.
655 Third Avenue, 8th Floor
New York, NY 10017
Attention: Al Foreman
Telephone : (917) 460-7522

Willow's head office is located at:

Willow Biosciences Inc.
150, 2250 Boundary Road
Burnaby, BC
V5M 3Z3

SOURCE Tuatara Capital Fund II, L.P.


These press releases may also interest you

at 19:21
Unifor recognizes the federal government for delivering a budget that pushes social progress and jobs in the face of economic inequities, relentless affordability pressures and stubbornly high interest rates. ...

at 19:20
Children today are facing a 'polycrisis' of generational shocks and stresses including high costs of living, record-breaking rises in temperatures due to climate change, and the lasting impacts of the most severe pandemic in a century. To address...

at 19:18
7-Eleven, Inc. ("7-Eleven"), the premier chain in the convenience-store industry, announced today the successful completion of its acquisition of 204 stores from Sunoco LP, which includes Stripes® convenience stores and Laredo Taco Company®...

at 19:05
The federal government's housing strategy is a long-awaited step forward to build more homes, but significantly more investment is needed to address critical infrastructure needs and the housing crisis, says Canada's construction industry. The...

at 19:05
A news report from chinadaily.com.cn: The Digital Silk Road Development Forum of the World Internet Conference aims to build a...

at 19:00
The United Steelworkers union acknowledge the positive steps taken by the federal government in Budget 2024 to uphold workers' rights and advance sustainable job creation but emphasizes the need for swift action on critical issues that remain...



News published on and distributed by: